ANIP ANI PHARMACEUTICALS INC Product Launches 8-K Filing 2025 - FDA Approval On March 14, 2025, ANI Pharmaceuticals announced that the FDA approved an expanded label for ILUVIEN to treat chronic non-infectious uveitis affecting the eye.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC